Authors/Disclosures
|
Tzvetelina D. Dimitrova, MD
(National Institutes of Health/NIMH)
|
No disclosure on file |
|
Nir Giladi, MD, FAAN
(Tel-Aviv Medical Center)
|
Dr. Giladi has received personal compensation in the range of $0-$499 for serving as a Consultant for Sionara. Dr. Giladi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDerm. Dr. Giladi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pharma2B. Dr. Giladi has stock in Vibrant. Dr. Giladi has stock in Lysosomal Therapeutics . The institution of Dr. Giladi has received research support from The Michael J Fox Foundation. The institution of Dr. Giladi has received research support from The National Parkinson Foundation. The institution of Dr. Giladi has received research support from The European Union . The institution of Dr. Giladi has received research support from The Israel Science Foundation. The institution of Dr. Giladi has received research support from Biogen . The institution of Dr. Giladi has received research support from Ionis. The institution of Dr. Giladi has received research support from Sieratzki Family Foundation . The institution of Dr. Giladi has received research support from The Aufzien Academic Center in Tel-Aviv University. |
|
William Bara-Jimenez, MD
(Bethesda Neuroscience Clinic)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Madhavi Thomas, MD
(North Texas Movement Disorders Institute, Inc)
|
No disclosure on file |
|
Trevor J. Resnick, MD
|
Dr. Resnick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Resnick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for supernus. Dr. Resnick has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Francesco Bibbiani, MD
(Eisai)
|
Dr. Bibbiani has nothing to disclose. |
|
Ruth Djaldetti, MD
|
No disclosure on file |
|
Rui Li
(McGill University)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Thomas N. Chase, MD
(GT Pharmaceuticals, Inc)
|
Dr. Chase has received personal compensation for serving as an employee of Chase Therapeutics Corporation. Dr. Chase has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Riverside Pharmaceuticals Corporation. Dr. Chase has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Chase Therapeutics Corporation. Dr. Chase has received stock or an ownership interest from Chase Therapeutics Corporation. Dr. Chase has received stock or an ownership interest from Riverside Pharmaceuticals Corporation. |
|
Connie C. Marras, MD
(Toronto Western Hospital)
|
Dr. Marras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine Biosciences. The institution of Dr. Marras has received research support from Theravance Inc. The institution of Dr. Marras has received research support from Centogene. |
|
Yael Cohen
|
Yael Cohen has nothing to disclose. |
|
Tamar Rachmilewitz
|
No disclosure on file |
|
Sheila Oren, MD, MBA
(Neuroderm)
|
Sheila Oren, MD, MBA has received personal compensation for serving as an employee of Neuroderm. Sheila Oren, MD, MBA has received personal compensation in the range of $0-$499 for serving as a Consultant for Neuroderm. |